Latest News - Thermo Fisher Scientific
Top Corporates Hub
Thermo Fisher Scientific
Sodium Perborate Company Evaluation Report 2025 | Thermo Fisher, Merck KGaA, and Evonik Treibacher Lead with Strategic Expansions, Strong Distribution, and Eco-Friendly Innovation
01.08.2025 10:15
Discover the comprehensive insights of the global Sodium Perborate market with the Sodium Perborate Companies Quadrant. This analysis identifies key market players, technological advancements, and emerging industry trends, spotlighting the Top 10 companies as quadrant leaders. Renowned for its strong oxidizing properties, sodium perborate is essential in cleaning, textiles, healthcare, and more. Its eco-friendly profile drives significant market growth amid rising hygiene awareness and sustainab
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens Healthineers
29.07.2025 08:31
The North America Autoimmune Disease Diagnostics Market is projected to grow from USD 1.96 billion in 2024 to USD 3.5 billion by 2033, at a CAGR of 6.66%. Key growth drivers include rising incidence of autoimmune conditions like rheumatoid arthritis and type 1 diabetes, advancements in diagnostic technologies, and increased healthcare investments. Enhanced diagnostic techniques such as ELISA and next-gen sequencing are improving early detection, with hospitals and clinics expanding sophisticated
CFOs On the Move: Week ending July 25
25.07.2025 10:00
BankUnited hires a Wells Fargo exec to succeed its longtime CFO, Thermo Fisher announces CFO retirement and successor appointment and Patreon names its first finance chief.
Thermo Fisher Scientific’s Chief Financial Officer, Stephen Williamson, to Retire in Early 2026
23.07.2025 13:00
WALTHAM, Mass., July 23, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that Stephen Williamson, senior vice president and chief financial officer (CFO), has decided to retire from the company, effective March 31, 2026. The company’s board of directors has approved the appointment of Jim Meyer, currently vice president of financial operations, to succeed Williamson as CFO, effective March 1, 2026.
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid US-Japan Deal
23.07.2025 12:49
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively trad
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
23.07.2025 11:10
Thermo Fisher (TMO) delivered earnings and revenue surprises of +2.68% and +1.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Call Transcript
23.07.2025 10:57
Thermo Fisher Scientific Inc. (NYSE:TMO) Q2 2025 Earnings Conference Call July 23, 2025 8:30 AM ETCompany ParticipantsMarc N.
Thermo Fisher beats quarterly estimates on resilient demand for its tools and services
23.07.2025 10:46
Shares of the medical equipment maker were up 2.5% in premarket trading. The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies. Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients.
Thermo Fisher shares climb as Q2 top and bottom line exceed estimates
23.07.2025 10:40
Investing.com -- Thermo Fisher Scientific Inc (NYSE:TMO) reported second-quarter earnings that topped expectations, with revenue also coming in ahead of forecasts.
Thermo Fisher Scientific Profit, Revenue Rise
23.07.2025 10:29
EARNINGS Thermo Fisher Scientific posted better-than-expected profit and revenue in its latest quarter. The company, which sells lab equipment, chemicals and tests, among other life-sciences services and products, recorded net income of $1.
Thermo Fisher: Q2 Earnings Snapshot
23.07.2025 10:06
WALTHAM, Mass. AP) — Thermo Fisher Scientific Inc. TMO) on Wednesday reported second-quarter profit of $1.62 billion.
Thermo Fisher (NYSE:TMO) Posts Better-Than-Expected Sales In Q2
23.07.2025 10:06
Life sciences company Thermo Fisher (NYSE:TMO) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 3% year on year to $10.86 billion. Its non-GAAP profit of $5.36 per share was 2.3% above analysts’ consensus estimates.
Thermo Fisher Scientific Reports Second Quarter 2025 Results
23.07.2025 10:00
WALTHAM, Mass., July 23, 2025--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2025.
Cancer Diagnostics Market Outlook, Forecast Trends and Growth Report 2025-2034 | Increasing Fundings and Investments, Advanced Liquid Biopsy Technologies and Early Detection Methods Fuelling Growth
23.07.2025 08:05
The global cancer diagnostics market, valued at USD 23.84 billion in 2024, is forecasted to grow at an 11.5% CAGR, reaching USD 70.80 billion by 2034. Key drivers include rising cancer cases, early detection initiatives, and technological advances like AI and liquid biopsies. The robust market includes leaders like Roche, Thermo Fisher, and expanding regions such as North America. Cancer Diagnostics Market Cancer Diagnostics Market Dublin, July 23, 2025 (GLOBE NEWSWIRE) -- The "Cancer Diagnostic
Thermo Fisher Scientific 2Q Profit, Revenue Rise
23.07.2025 06:18
Thermo Fisher Scientific 2Q Profit, Revenue Rise
Solventum: Appealing Again
22.07.2025 09:12
Despite near-term earnings pressure from higher costs and separation expenses, Solventum's organic growth has accelerated and future guidance has improved. Learn more on SOLV stock here.
India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher
21.07.2025 10:02
The market's 6.10% CAGR reflects advances in molecular diagnostics, healthcare infrastructure expansion, and personalized medicine. Key trends include companies like Sysmex enhancing local operations and WHO expanding diabetes-related IVDs. Abbott, Qiagen, Quidel, and Danaher lead the market's innovation-driven growth.Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The "India In Vitro Diagnostics Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering. The India in vi
Cell‑Based Assays Report 2025: Key Market Drivers, Tech Trends & Competitive Landscape to 2030
21.07.2025 08:03
The global cell-based assays market is set to grow from USD 17.84 billion in 2025 to USD 27.55 billion by 2030, marking a CAGR of 9.1%. This surge is fueled by the rising demand in drug discovery and increased R&D investments by the pharmaceutical and biotech industries. The prevalence of cancer is boosting the need for advanced therapies, while the growth of cell-based assays applications in chronic diseases and personalized medicine further propels market expansion. In 2024, the drug discovery
Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi
20.07.2025 04:35
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best long term low volatility stocks to buy now. On July 16, Thermo Fisher Scientific Inc. (NYSE:TMO) announced plans to strategically expand its partnership with Sanofi to support additional drug product manufacturing in the United States. As part of the partnership, Thermo Fisher Scientific Inc. (NYSE:TMO) […]